Monographie - Omeprazole sodium

Ultimele actualizari :
29/10/2024

Omeprazole sodium

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Antra	Elvetia, Germania, Italia
Biomezol	Ecuador
Cezole	Peru
Ciplaprazole	Columbia
Dinsadrix	Mexic
Fendiprazole	Argentina
Finulcer	Mexic
Fordex	Venezuela
Gaspiren	Brazilia
Gastromax	Venezuela
Gerdex	Mexic
Haitrax	Mexic
Helicid	Polonia
Imaroz	Chilli
Inhibitron	Mexic
Ipproton	Arabia Saudita, Tunisia
Klomeprax	Argentina, Ecuador
Lordin	Grecia
Losec	Arabia Saudita, Austria, Belgia, Italia, Marea Britanie, Olanda, Polonia, Turcia
Mepral	Italia
Omeprazen	Italia
Omeprazol	Germania
Omeprazole	Franta
Oprazole	Arabia Saudita
Penrazol	Grecia
Rizek	Arabia Saudita
Timezol	Argentina
Ulcozol	Argentina
Ultop	Croatia

Bibliografie : Omeprazole sodium

	tip	publicare
186	ziar	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264	ziar	Leboucher G, Charpiat B. Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Pharm Hosp Fr 1997 ; 121: 124.
1703	ziar	Schuster F, Bernard R. Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Krankenhauspharmazie 1995 ; 16: 101-103.
2231	ziar	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311	ziar	Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. J Clin Pharm Ther 2009 ; 34: 25-31.
3332	Laborator	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3658	Laborator	Omeprazole - Summary of Product Characteristics. Sandoz 2014
3823	ziar	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3871	poster	Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 2016
3976	ziar	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	poster	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4316	ziar	Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion. J Pharm Technol 2006 ;22:95-98.
4642	poster	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021

Mentions Légales